SB-728-T
SB-728-0902
Phase 1 gene_therapy completed
Quick answer
SB-728-T for HIV Infection is a Phase 1 program (gene_therapy) at SANGAMO THERAPEUTICS, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SANGAMO THERAPEUTICS, INC
- Indication
- HIV Infection
- Phase
- Phase 1
- Modality
- gene_therapy
- Status
- completed